Tag: Wallaby Medical
Wallaby/phenox officially announces global launch of Pegasus HPC stent system
Wallaby/phenox has officially announced the successful global launch of its novel Pegasus hydrophilic polymer coating (HPC) stent, having first unveiled the device at the 2022...
Wallaby acquires phenox to accelerate global expansion in neurovascular space
Wallaby Medical today announced that it has acquired phenox GmbH—including phenox's femtos GmbH—for a total consideration of approximately €500 million including milestone payments.
The acquisition is...
Wallaby Medical launches Avenir coil system for haemorrhagic stroke treatment in...
Wallaby Medical has partnered with Japan Lifeline (JLL) to bring its Pharmaceuticals and Medical Devices Agency (PMDA)-approved Avenir coil system to the Japanese market....
Wallaby Medical closes US$45 million Series C funding
Wallaby Medical, a medical device company focused on stroke treatment, has announced the closing of a US$45 million Series C funding.
This round of funding...
Wallaby Medical raises funds to accelerate device development for stroke treatment
Wallaby Medical announced it has recently closed a series B+ financing round worth more than US$20 million. The company focuses on developing and commercialising...
